Shanghai Moyom

Shanghai Moyom Biotechnology is an innovative Chinese medical aesthetics company specializing in regenerative medicine and biomaterials. Founded in 2018, the company focuses on the research, development, and manufacturing of nano-medical biomaterials and Class III absorbable implants. Its flagship brand, Aphranel, features the MagiCCrystal CaHA Filler, which is the first calcium hydroxylapatite (CaHA) microsphere-based dermal filler developed in China to receive NMPA Class III medical device certification. Moyom's products utilize proprietary technologies, including the ACD-MT raspberry-like through-hole microsphere morphology and PCD-ETT physically crosslinked gel matrix, to provide structural support and stimulate collagen regeneration. The company's portfolio also includes the PurElsa skinbooster series for skin renewal and barrier repair.